“…Rates of curative therapy receipt were consistent across study design (OR 2.18 [95% CI 1.94–2.45] among retrospective studies [17],[19],[20],[26],[28]–[30],[32]–[36],[38],[43],[44],[46],[47],[49],[50],[51],[53]–[55],[58]–[63] versus 2.37 [95% CI 1.51–3.72] among prospective studies [21],[22],[31],[37],[40]), study period (OR 2.12 [95% CI 1.25–3.61] among studies assessing surveillance prior to 1990 [26],[44],[50],[54] versus 2.23 [95% CI 1.87–2.67] among studies assessing surveillance in the 1990s [17],[19],[20], versus 2.13 [95% CI 1.85–2.44] among studies assessing surveillance after 2000 [21],[32],[34],[35],[37],[38],[43],[46],[47],[58],[61],[63]), and type of surveillance tests (OR 2.23 [95% CI 1.83–2.71] with ultrasound alone [20],[28],[32],[38],[46],[47],[61],[62] versus 2.19 [95% CI 1.89–2.53] with ultrasound and/or AFP [17],[19],[22],[26],[29]–[31],[34]–…”